These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8390813)

  • 1. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular activity of azithromycin against bacterial enteric pathogens.
    Rakita RM; Jacques-Palaz K; Murray BE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1915-21. PubMed ID: 7810998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
    Jones K; Felmingham D; Ridgway G
    Drugs Exp Clin Res; 1988; 14(10):613-5. PubMed ID: 2854515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of the new oral macrolide azithromycin.
    Neu HC; Chin NX; Saha G; Labthavikul P
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):541-4. PubMed ID: 2846300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.
    Retsema J; Girard A; Schelkly W; Manousos M; Anderson M; Bright G; Borovoy R; Brennan L; Mason R
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1939-47. PubMed ID: 2449865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of azithromycin against clinical isolates of family enterobacteriaceae: A comparison of its minimum inhibitory concentration by three different methods.
    Chayani N; Tiwari S; Sarangi G; Mallick B; Mohapatra A; Paty BP; Das P
    Indian J Med Microbiol; 2009; 27(2):107-10. PubMed ID: 19384031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin.
    Retsema JA; Girard AE; Brennan LA; Cimochowski CR; Faiella JA
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):843-6. PubMed ID: 1662628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
    Imagawa Y; Fukuyama M; Kawakami K; Suda O
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter.
    Casanovas-Moreno-Torres I; Gutiérrez-Soto B; Modovan TD; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    New Microbiol; 2020 Oct; 43(4):198-200. PubMed ID: 33021318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
    Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
    Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
    Mehaffey PC; Putnam SD; Barrett MS; Jones RN
    J Clin Microbiol; 1996 Feb; 34(2):479-81. PubMed ID: 8789046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi.
    Metchock B
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():29-31. PubMed ID: 2154435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic sensitivity of enteropathogenic bacteria isolated from patients in a Sharjah hospital.
    Damjanovic V; Furtado M; Patmore M
    J Hyg (Lond); 1984 Apr; 92(2):205-8. PubMed ID: 6368686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Chida T; Nakaya R
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of activity of azithromycin.
    Williams JD
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):813-20. PubMed ID: 1662624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of MC-352, a new 16-membered macrolide.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of bacterial pathogens associated with infectious diarrhea in Djibouti.
    Mikhail IA; Fox E; Haberberger RL; Ahmed MH; Abbatte EA
    J Clin Microbiol; 1990 May; 28(5):956-61. PubMed ID: 2351738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.